Media & Analysis

David Munis Zepernick

David Munis Zepernick

Head of Business Development and Public Affairs

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

MVA chairman, Søren Bregenholt welcomes high Swedish life science ambitions for the Stockholm region- interview in today´s Medwatch

In a recently published report by the Stockholm Chamber of Commerce titled "Vital for the Capital" which describes the importance of the life science industry to the regions of Stockholm and Uppsala, Greater Stockholm has set a goal to become one of the top five leading life science regions in the world in 2025. In today´s Medwatch-interview (in Danish), Medicon Valley Alliance chairman of the Board of Directors, Søren Bregenholt, welcomes the competition and looks forward to even more...

MVA CEO, Petter Hartman, interviewed by PharmaBoardroom

In the recently published interview in PharmaBoardroom, MVA CEO, Petter Hartman gives the readers a general introduction to the Medicon Valley life science cluster and how we at the bi-nationale Danish-Swedish life science cluster organisation, Medicon Valley Alliance, not only work to provide an arena for our members to share knowledge, meet potential partners, and learn and get inspired from each other, but also act as a collaborative platform and project incubator; leveraging Scandinavia’s...

Anette Steenberg appointed new CEO of Medicon Valley Alliance

”We are very happy to welcome Anette to MVA, who will play a key role in our ongoing efforts to strengthen the framework conditions for life science in Medicon Valley. With her very substantial experience from working with public-private life science collaboration and her extensive network in both Denmark and Sweden, I am certain that she will be a great asset to our organisation and the Medicon Valley life science cluster as such.” says MVA chairman of the Board of Directors, Søren...

The ReproUnion project is truly unique. Our new 10 minute-movie explains why!

Last week our ReproUnion colleagues launched the ReproUnion film, which introduces you to a decade of Repro-collaboration and how the project has helped young researchers and patients realize their dreams and literally make Medicon Valley the cradle of life. Watch the film on the ReproUnion YouTube channel and learn more about the ReproUnion project on the project website.

3 Q&A interview with CEO, Ömer Özkan, MVA-member company, Enbiosis Biotechnology

Q1: As a microbiome company with offices in the UK, The Netherlands, Turkey and Ukraine, why have you decided to become a member of our Danish-Swedish life science cluster organization? Prior to Copenhagen Capacity reaching out to us, we had not even considered the possibility of investing in Denmark. We were considering Berlin in Germany and Boston/San-Francisco in the US. However, as we learned more about Greater Copenhagen’s life sciences industry we were very impressed and attracted by a...

“Sweden tops the European Commissions ranking of innovative countries, but we shouldn´t rest on our laurels” is one of the key messages in MVA CEO Petter Hartman´s opinion piece in Life Science Sweden

Collaboration - "Samverka" is key, and actually a key ingredient  in what has made Sweden (and Finland and Denmark) so succesful and innovative in the past. But we must make sure that we collaborate with a strategic purpose, MVA CEO, Petter Hartman, points out in his recent opinion piece

“Think global, think big” interview with Medicon Valley Alliance chairman of the Board of Directors, Søren Bregenholt

"Think global, think big" is the title of the interview with MVA chairman of the Board of Directors, Søren Bregenholt, CEO of Alligator Bioscience AB, in the special "Life Science" magazine distributed with  Berlingske Wednesday 22nd of September. Key message: We should replace the more narrow national perspective and protectionistic approach by increased collaboration and networking in the Danish-Swedish Greater Copenhagen Region for our life science cluster to be able to compete globally....

“The Oresund region aims at becoming Europe’s microbiome Mecca” interview with MVA Senior Strategy and Project Manager, Sarah Lidé in Life Science Sweden

The Medicon Valley Alliance’s ambition is for Skåne and the Copenhagen region to become world leaders in microbiome research. No less! In the recently published article in Life Science Sweden "The Oresund region aims at becoming Europe’s microbiome Mecca", MVA´s Sarah Lidé elaborates on the ambitions and activities of the Microbiome Signature Project which, together with MVA´s Microbiome Network, form the core of MVA´s microbiome related activities. The Microbiome Signature Project is funded...

Interview with, Frederik Rahl, from MVA-member, Spotlight Group, about IPO in Sweden for Danish life science companies

In today´s edition of Øresund News, we strogly recommend the interview (in Danish/Swedish) with Fredrik Rahl, Director of Sales & Capital Markets i Sedermera Fondkommission, about IPO in Sweden for Danish life science companies. If you are curious to know more about life science across the Øresund, you can download the latest published results of the Greater Copenhagen Life Science Analysis project and/or visit/revisit the latest State of Medicon Valley analysis on MVA´s webpage.

MVA-facilitated roundtable discussion with Swedish Minister for Foreign Trade and Nordic Affairs, Anna Hallberg

Today Medicon Valley Alliance, Embassy of Sweden in Copenhagen and Business Sweden had the opportunity of welcoming the Swedish Minister for Foreign Trade and Nordic Affairs, Anna Hallberg to a roundtable discussion with business leaders in the region. The MVA moderated discussion highlighted the importance of a strong cross border collaboration within life science and how we can increase our competitiveness by reducing cross-border obstacles and create stronger incentives for research...